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Cellular/Molecular
Galanin-Expressing GABA Neurons in the Lateral
Hypothalamus Modulate Food Reward and
Noncompulsive Locomotion
Emily Qualls-Creekmore,1 X Sangho Yu,1 X Marie Francois,1 John Hoang,1 X Clara Huesing,1 Annadora Bruce-Keller,1
X David Burk,2 Hans-Rudolf Berthoud,1 Christopher D. Morrison,1 and Heike Münzberg1
1Neurobiology of Nutrition and Metabolism, and 2Cell Biology and Bioimaging Core, Pennington Biomedical Research Center, Louisiana State University
System, Baton Rouge, Louisiana 70808
The lateral hypothalamus (LHA) integrates reward and appetitive behavior and is composed of many overlapping neuronal populations.
Recent studies associated LHA GABAergic neurons (LHA GABA), which densely innervate the ventral tegmental area (VTA), with modu-
lation of food reward and consumption; yet, LHA GABA projections to the VTA exclusively modulated food consumption, not reward. We
identified a subpopulation of LHA GABA neurons that coexpress the neuropeptide galanin (LHA Gal). These LHA Gal neurons also modulate
food reward, but lack direct VTA innervation. We hypothesized that LHA Gal neurons may represent a subpopulation of LHA GABA neurons
that mediates food reward independent of direct VTA innervation. We used chemogenetic activation of LHA Gal or LHA GABA neurons in
mice to compare their role in feeding behavior. We further analyzed locomotor behavior to understand how differential VTA connectivity
and transmitter release in these LHA neurons influences this behavior. LHA Gal or LHA GABA neuronal activation both increased operant
food-seeking behavior, but only activation of LHA GABA neurons increased overall chow consumption. Additionally, LHA Gal or LHA GABA
neuronal activation similarly induced locomotor activity, but with striking differences in modality. Activation of LHA GABA neurons
induced compulsive-like locomotor behavior; while LHA Gal neurons induced locomotor activity without compulsivity. Thus, LHA Gal
neurons define a subpopulation of LHA GABA neurons without direct VTA innervation that mediate noncompulsive food-seeking behav-
ior. We speculate that the striking difference in compulsive-like locomotor behavior is also based on differential VTA innervation. The
downstream neural network responsible for this behavior and a potential role for galanin as neuromodulator remains to be identified.
Key words: compulsivity; DREADD; energy expenditure; feeding; locomotor activity; marble-burying test
Introduction
The lateral hypothalamic area (LHA) is implicated in feeding,
food reward, and other motivated behaviors. Early research es-
tablished that the LHA is necessary to maintain homeostatic feed-
ing behaviors (Anand and Brobeck, 1951). Furthermore, rodents
show impressive motivation to self-administer electric stimula-
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Significance Statement
The lateral hypothalamus (LHA) regulates motivated feeding behavior via GABAergic LHA neurons. The molecular identity of
LHA GABA neurons is heterogeneous and largely undefined. Here we introduce LHA Gal neurons as a subset of LHA GABA neurons
that lack direct innervation of the ventral tegmental area (VTA). LHA Gal neurons are sufficient to drive motivated feeding and
locomotor activity similar to LHA GABA neurons, but without inducing compulsive-like behaviors, which we propose to require
direct VTA innervation. Our study integrates galanin-expressing LHA neurons into our current understanding of the neuronal
circuits and molecular mechanisms of the LHA that contribute to motivated feeding behaviors.
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tions to the LHA (Olds and Milner, 1954) and the LHA is well
established for its interaction with the mesolimbic dopamine re-
ward circuitry in the brain (Peyron et al., 1998; Korotkova et al.,
2003; Leinninger et al., 2009; Kempadoo et al., 2013). The LHA is
a large region with a heterogeneous molecular makeup and a
diverse pattern of inputs and outputs (Swanson et al., 2005; Hahn
and Swanson, 2010; Bonnavion et al., 2016). Much research has
focused on defining the molecular signature of LHA neurons and
their neural projections that regulate feeding and food reward
(Berthoud and Münzberg, 2011).
Recent studies have focused on GABAergic LHA (LHAGABA)
neurons and associated neural circuits for their involvement in
feeding and especially food reward (Jennings et al., 2015; Nieh et
al., 2015). Optogenetic and chemogenetic stimulation and inhi-
bition of LHAGABA neurons had opposing effects on operant food
seeking and food consumption. Interestingly, in vivo visualiza-
tion of LHAGABA neuronal activity highlighted that food-seeking
versus food-consumption behaviors are represented by activation of
anatomically distinct GABA populations (Jennings et al., 2015).
Similarly, activation of all ventral tegmental area (VTA)-projecting
LHA neurons enhanced sucrose seeking, while selective activation of
VTA-projecting GABAergic LHA neurons promotes food con-
sumption but not sucrose seeking (Nieh et al., 2015).
We recently described a subpopulation of LHA neurons that
express the neuropeptide galanin (LHAGal) together with leptin
receptors and neurotensin (Berthoud and Münzberg, 2011;
Laque et al., 2013). These LHAGal neurons modulate food reward
without promoting overall food consumption (Laque et al.,
2015). Also, LHAGal neurons do not project to the VTA, but
instead innervate the locus ceruleus (LC) and local LHA neurons
(Laque et al., 2015). Galanin often acts as an inhibitory neuro-
peptide, and many galanin neurons coexpress the inhibitory neu-
rotransmitter GABA (Melander et al., 1986; Sherin et al., 1998).
Thus, we hypothesized that LHAGal neurons may represent a
distinct subset of LHAGABA neurons that selectively modulates
food reward, but not overall food consumption.
To test this hypothesis, we compared operant food-seeking
behavior and overall chow consumption following chemogenetic
activation of LHAGal neurons or LHAGABA neurons. Here we
show that LHAGal neurons are sufficient to promote operant food
seeking, while overall chow consumption remained unchanged. In
addition, we discovered that activation of LHAGal or LHAGABA neu-
rons robustly enhanced locomotor activity, but that GABA-induced
hyperactivity was associated with a striking, compulsive-like behav-
ior not observed with LHAGal neuron-induced hyperactivity.
Thus, our data suggest that LHAGal neurons represent a sub-
population of LHAGABA neurons that promotes food reward in-
dependent of direct VTA innervation, while VTA innervating
LHAGABA neurons may be required to induce overall chow con-
sumption. Furthermore, we show that targeting exclusively
galanin-expressing LHA neurons attenuates compulsive-like lo-
comotor behavior, while maintaining food-seeking behavior.
The clear behavioral distinction of molecularly defined subsets of
LHAGABA neurons could have important implications for treat-
ment strategies of feeding and psychiatric disorders.
Materials and Methods
Animals
All experimental procedures were approved by the Institutional Animal
Care and Use Committee at the Pennington Biomedical Research Center.
Mice were bred and housed at 22°C on a 12 h light/dark cycle. Food and
water were available ad libitum unless otherwise specified. GalCre mice
were generated in house as previously described (Laque et al., 2015) and
VgatCre mice were generously provided by Dr. Bradford B. Lowell, Beth
Israel Deaconess Medical Center and Harvard Medical School (Vong et
al., 2011). Experimental animals were bred and used from homozygous
breeding colonies. Gal TgGFP/VgatTom mice were generated by cross-
breeding Gal TgGFP mice [Stock Tg(Gal-EGFP)109Gsat, #0163420UCD,
Mutant Mouse Regional Resource Center; Laque et al., 2013] with VgatCre
mice and Rosa-tomatof/f mice [B6.Cg-Gt(ROSA)26Sortm14(CAG-td-
Tomato)Hze/J, Jackson Laboratory, stock #007914] and were used for
histology and cell-count experiments as hemizygous GalTgGFP, double
heterozygous VgatTom mice.
Genotyping
Genotype for experimental animals was determined by PCR using the
following primers: GalCre: cre, forward, 5-CCT CTC CAC CCA AGC
GGC CGG AGA ACC-3; cre, reverse, 5-CCG GCT CCG TTC TTT GGT
GGC CCC TTC GCG-3; wild type, forward, 5-TCC TGA GAC CAT
GTC CAC TG-3; wild type, reverse, 5-CTG CCA CTC CTG TGA TCT
GA-3; VgatCre: wild type, forward, 5-CTT CGT CAT CGG CGG CAT
TCT G-3; wild type, reverse, 5-CAG GGC GAT GTG GAA TAG AAA-
3; cre, reverse, 5-ATC GAC CGG TAA TGC AGG CAA-3; Gal TgGFP:
forward, 5-TAT ATC ATG GCC GAC AAG CA-3; reverse, 5-GAA
CTC CAG CAG GAC CAT GT-3; Rosa-tomato f/f: wild type, forward,
5-AAG GGA GCT GCA GTG GAG TA-3; wild type, reverse, 5-CCG
AAA ATC TGT GGG AAG TC-3: loxP, forward, 5-GGC ATT AAA
GCA GCG TAT CC-3; loxP, reverse, 5-CTG TTC CTG TAC GGC ATG
G-3.
Stereotaxic surgery
Viral injections were done as described previously (Rezai-Zadeh et al.,
2014); briefly, mice were anesthetized using inhaled isofluorane (2%
isofluorane/1 L O2/min) and mounted into a stereotaxic frame (Stereo-
taxic Alignment System, Kopf Instruments) to enhance anatomically
reproducible injections into the LHA (0.9 mm lateral, 1.35 mm cau-
dal, and 5.4 mm ventral to bregma based on the Paxinos mouse-brain
atlas; Paxinos and Franklin, 2004). Either AAV5-hSyn-DIO-hM3Dq-
mCherry [DREADD (designer receptor exclusively activated by designer
drugs)-Gq, titer 6  10 12 cfu/ml] or AAV5-hSyn-DIO-mCherry (con-
trol, titer 6  10 12 cfu/ml) were injected bilaterally (200 nl per site at a
rate of 20 nl/30 s) into the LHA. Guide cannula and injector remained in
place for 5 min following injection to allow for diffusion into the paren-
chyma and to prevent backflow up the cannula tract. Skull access holes
were filled using bone wax (Lukens, #901) and the incision was closed
with stainless steel wound clips (CellPoint Scientific, #203-1000) and
postoperative care was given (bupivicaine/lidocaine: 2.5–12.5 mg/kg
once at incision; carprofen: 5 mg/kg once daily for 72 h; once warm
saline, i.p.). Mice recovered for 2–3 weeks to allow sufficient viral expres-
sion before further experimental testing.
Two cohorts of virus-expressing mice were generated. Cohort 1 had ex-
clusively male mice (GalCre: n  4 control, n  9 DREADD-Gq; VgatCre: n 
4 control, n  8 DREADD-Gq virus), Cohort 2 had mixed male and female
mice (GalCre: control virus, n  3 males, 3 females; DREADD-Gq virus, n 
4 males, 5 females).
Behavioral experiments
Clozapine-N-oxide dose selection. Initial repeatable measurements, such
as those related to locomotor activity, energy expenditure, and food in-
take, were performed with multiple doses of the designer drug clozapine-
N-oxide (CNO; ligand for the DREADD-Gq receptor) to identify the
most efficient CNO dose. Nonrepeatable behavioral experiments (oper-
ant conditioning, ensure intake, marble burying) were performed with a
single CNO dose (1 mg/kg), which has been also used by several other
studies (Jennings et al., 2015; Nakajima et al., 2016). For LHAVgat operant
testing experiments, 1 mg/kg CNO induced excessive compulsive behav-
iors (gnawing) in all animals and interfered with the mouse’s ability to
perform the operant task. Thus, all LHAVgat mice were tested at multiple
CNO doses (0.1–1 mg/kg) to identify individual CNO doses where mice
were able to properly perform the operant task. For the marble burying,
which can be only performed once, we chose the lowest CNO dose (0.1
mg/kg) tested, to minimize excessive compulsive behavior.
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Metabolic parameters. Animals from cohort 1 were adapted to meta-
bolic chambers (TSE Systems) for 1 week before data were collected for
locomotor activity (beam breaks) and oxygen consumption (VO2 ml/
kg/h) in 30 min intervals. For stimulation experiments, animals were
intraperitoneally injected with PBS or CNO (0.1 mg/kg or 1 mg/kg) at
	1000 h.
Locomotor activity was also measured with subcutaneously implanted
telemetric radio transmitters (G2 E-Mitter, Starr Life Sciences), detected
with individual receivers (Series 4000, Starr Life Sciences), and recorded
with VitalView software (Starr Life Sciences). Telemetric radio transmit-
ters were surgically implanted on the dorsal surface of each mouse in the
interscapular area. Mice recovered for 1 week before measurement of
locomotor activity via telemetry. Measurements occurred in the home
cage and, for neuronal stimulation experiments, mice were intraperito-
neally injected with PBS or CNO (0.1 mg/kg or 1 mg/kg, i.p.) at 	1000
Zeitgeber time and locomotor activity was recorded continuously (every
minute) for 24 h.
Motivated food intake. DREADD-Gq animals from cohort 1 (n  8 per
genotype) were food-restricted during the training phase of the experi-
ment. This greatly facilitates operant conditioning learning by encourag-
ing exploratory behavior and increasing motivation to work for food.
Food restriction started 2 weeks before the operant training session with
2.5–3.5 g/d standard laboratory chow (Laboratory Rodent Diet 5001,
LabDiet; distributed during the light cycle at 1200 Zeitgeber time) until
animals reached 90% of their baseline body weight. Operant condition-
ing chambers (Med Associates) were 	15.9  14.0  12.7 cm, with a
house light, wire bar floor, two lighted nose-poke holes with infrared
beams, and a pellet dispenser that released reward pellets into a hopper
located between the nose-poke holes. Mice were acclimated to sucrose
reward pellets in their home cage 2 d before operant training to prevent
neophobia. Training occurred in the following four steps with illumi-
nated nose-poke holes marking the “correct” (rewarded) hole: Step
1—autoshaping: one reward per nose poke, both holes are marked cor-
rect; Step 2—fixed ratio 1 (FR1): one reward per one correct nose poke,
only one hole is marked correct; Step 3—fixed ratio 5 (FR5): one reward
per five consecutively correct nose pokes, only one hole is marked cor-
rect; Step 4 —progressive ratio (PR): one reward per increasing consec-
utive correct nose pokes on an exponential scale (i.e., 1, 2, 4, 6, 9, 12, 15,
20, 25, 32, 40, 50, 62, 77, 95, 118 . . .; Richardson and Roberts, 1996).
Autoshaping was performed for 1 d in a 30 min session to acclimate the
mice to the chambers and reinforce nose-poke behavior; FR1, FR5, and
PR training were each performed daily for 5–7 d until mice achieved
stable performance (10% variation in number of correct nose pokes
and a 3:1 ratio of correct/incorrect responses over a 3 d period). Fixed
ratio training consisted of 30 min sessions and PR sessions were 60 min or
ended when the mouse did not complete any nose poke for a 5 min
period (break point). Once training was completed, mice were returned
to ad libitum feeding until returning to baseline bodyweight. PR testing
occurred during the light cycle at 1200 Zeitgeber time. Stimulation of
virally infected neurons was done with intraperitoneal injections of PBS
or CNO at doses from 0.05 to 1 mg/kg body weight 1 h before PR testing.
Data used for analysis included the total number of correct nose pokes
(collectively leading to reward), total number of incorrect nose pokes
(not leading to reward), and total number of rewards achieved during the
PR testing session.
Palatable food intake. Mice from cohort 1 had access to a liquid palat-
able diet (Ensure, 97 kcal/ml) for 1 h daily over 5 d. On day 4 and 5, mice
received counterbalanced intraperitoneal injections of either PBS or
CNO (0.1 or 1 mg/kg body weight) 1 h before Ensure access; intake (in
grams) was measured following each training or testing session.
Chow intake. Intake (in grams) of standard laboratory chow (Purina
5001) was measured in metabolic cages (TSE Systems) and analyzed as
cumulative food intake for 3 and 24 h following intraperitoneal injection
of either PBS or CNO (dose range of 0.1–1 mg/kg body weight).
Marble-burying test. Standard mouse cages were filled with fresh bed-
ding to a depth of 5 cm and 16 marbles (	1 cm diameter) were evenly
spaced across the bedding. VgatCre mice from cohort 1 (n  4 control,
n  8 DREADD-Gq) and GalCre mice from cohort 2 (n  6 control, n 
9 DREADD-Gq) were placed in the cage for 30 min and allowed to
ambulate freely. Injection of CNO (1 mg/kg in GalCre mice, 0.1 mg/kg in
VgatCre mice) was administered 1 h before beginning the test. Please note,
the marble-burying test in part reflects the animal’s response to a novel
environment and is therefore only testable once per animal. Thus, in this
test we compared DREADD animals to a control virus group also treated
with CNO. A repeated PBS control injection would have confounded the
novelty of the marble-burying test. A photograph was taken of the cage
before and after the mouse was in the cage and data were analyzed to
determine the percentage of marbles buried while the mouse occupied
the cage. ImageJ (Abramoff et al., 2004) was used to quantify the visible
marble area in each photograph before and after the test. Data were
expressed as percentage area buried after testing time to reflect changes in
compulsive-like behaviors (Angoa-Perez et al., 2013).
Perfusion and immunohistochemistry
Two hours before perfusion, mice were injected with CNO (0.1 mg/kg or
1 mg/kg, i.p.) for later histochemical confirmation of CNO-induced neu-
ral activation as indicated by induction of the early-response gene cFos
(Rezai-Zadeh et al., 2014; Yu et al., 2016). Mice were deeply anesthetized
and transcardially perfused with ice-cold saline followed by 10% forma-
lin. Brains were harvested, postfixed in 10% formalin for 24 h, and then
transferred into 30% sucrose for cryopreservation until sectioning into
four representative series (30 m per section) throughout the brain using
a sliding microtome. One (of four) series of brain sections was processed
using free-floating immunohistochemistry. Sections were pretreated
with 1% H2O2 in methanol, 0.3% glycine, and 0.03% SDS, before block-
ing in 3% normal donkey serum, followed by incubation in primary
antibody, goat anti-c-Fos (1:200; Santa Cruz Biotechnology). Staining
was developed with the Vectastain Elite ABC kit (Vector Laboratories)
and 3,3-diaminobenzidine tetrahydrochloride kit (Metal-Enhanced
DAB Substrate Kit, Life Technologies) according to the manufacturers’
specification. After that, mCherry was further stained with rabbit anti-
dsRed (1:1000; Clontech) and detected with fluorescent-labeled second-
ary antibody (1:200; Alexa Fluor 594 donkey anti-rabbit, Thermo Fisher
Scientific). Brains from Gal TgGFP/VgatTom mice (n  4) were stained for
GFP using chicken anti-GFP (1:1000; Abcam) and detected with
fluorescent-labeled secondary antibody (1:200; Alexa Fluor 488 donkey
anti-chicken, Jackson ImmunoResearch Laboratories) and tdTomato
was stained for with rabbit anti-dsRed (1:1000; Clontech), which was
detected with fluorescent-labeled secondary antibody (1:200; Alexa
Fluor 594 donkey anti-rabbit, Thermo Fisher Scientific).
Cell counts
For quantification of colocalization of galanin and Vgat (marker for
GABA), we counted the number of galanin neurons colocalized with
Vgat. Within the LHA, galanin is concentrated around the fornix [peri-
fornical area (PFA)], and also in the anterior lateral LHA (indicated as
LHA). For cell counting, we sampled both of these regions, which are
located in two anatomical sections rostrocaudally. Images of LHA and
PFA regions were collected using a Leica SP5 confocal microscope with
488 and 594 nm lasers in sequential scanning mode. HyD detector gain
was fixed for all samples, z-section thickness was fixed at 2.6 m per step,
and the zoom was fixed at 1.4. The microscope had a 20, 0.70 numer-
ical aperture, dry objective. Brightness and contrast were modified with
identical settings (Adobe Photoshop, Adobe Systems) between brains to
better visualize GFP and tdTomato staining. We first counted the total
galanin-GFP-expressing neurons, and performed a second count of
galanin-GFP neurons also expressing tdTomato.
Data analysis
Statistical differences were analyzed using SigmaPlot (Systat Software).
Analysis included paired and independent t tests, two-way ANOVA, and
two-way repeated-measures ANOVA as further indicated in figure leg-
ends. For datasets that did not follow a normal distribution, nonpara-
metric analyses were applied using the Mann–Whitney rank sum test. A
p value 0.05 was considered statistically significant and denoted as
follows: *p  0.05, **p  0.01, ***p  0.001.
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Results
Galanin neurons in the LHA are
partially GABAergic
The neuropeptide galanin acts mostly in-
hibitory and galanin-expressing neurons
are often GABAergic. To directly address
the molecular identity of LHAGal neurons,
we generated double reporter mice
(Gal TgGFP/VgatTom mice, n  4; 1 male, 3
females) with transgenic GFP expression
in galanin neurons (Laque et al., 2013)
and conditional tdTomato expression
in vesicular GABA transporter (Vgat)-
positive neurons (Vong et al., 2011). We
found that approximately half of LHA
(45  9%) and 	30  6% of PFA galanin
neurons were GABAergic neurons and
that GABAergic galanin neurons repre-
sent a small fraction of overall LHAGABA
neurons (Fig. 1 A–F). Importantly,
LHAGABA neurons heavily innervate the
VTA (Nieh et al., 2015), while LHAGal
neurons do not directly project to the
VTA (Laque et al., 2015). Instead, LHAGal
neurons heavily innervate LHA orexin
neurons and the noradrendergic LC (Go-
forth et al., 2014; Laque et al., 2015). These
results indicate that LHAGal neurons rep-
resent a GABAergic subpopulation with a
unique molecular identity and previous
work also indicates a distinct projection
profile that can be distinguished from
the larger heterogeneous population of
GABAergic neurons in the LHA.
Chemogenetic activation of LHA Gal
neurons enhances food-seeking
behavior
Recent data have highlighted the entire
population of LHAGABA neurons as an im-
portant regulator of feeding behavior,
emphasizing the LHAGABA projections to
the VTA (LHAGABA  VTA projection) as
particularly important in motivated feed-
ing behaviors. Thus, here we tested
whether activation of non-VTA project-
ing LHAGal neurons would be sufficient to
modulate sucrose-seeking behavior.
We first targeted DREADD-Gq or
control virus into the LHA of GalCre mice
(LHAGal DREADD-Gq), which allowed
us to selectively activate LHAGal neurons
with systemic CNO injections. Viral ex-
pression was visualized via the fluorescent
marker mCherry to verify correct target-
ing throughout the LHA area (Fig. 2A,B). We verified neuronal
stimulation capability of DREADD-Gq histologically with CNO-
induced cFos expression in mCherry-positive neurons, which
was prominent in the PFA (Fig. 2C, left) and extended through
the LHA with some cFos-positive neurons in the zona incerta,
while mice injected with control virus (LHAGal Control) showed
little cFos in mCherry
 neurons (Fig. 2C, right).
To quantify sucrose-seeking behavior, we trained the mice for
operant responding with palatable sucrose pellets (Fig. 2D) and
to perform increasing numbers of nose pokes to receive a sucrose
pellet (PR testing). After stable PR performance, we activated
LHAGal neurons with systemic CNO injections (1 mg/kg) and
compared their motivated behavior with PBS-injected mice. Ac-
tivation of LHAGal neurons significantly increased the total num-
Figure 1. Galanin neurons in the LHA coexpress GABA. A, B, Overview of galanin-expressing (green) and Vgat-expressing (red)
neurons in the hypothalamus of Gal TgGFP/VgatTom mice (scale bar, 200 m). C, D, Confocal image of the LHA depicting the PFA
(C) and the LHA dorsal of the PFA (D) in Gal TgGFP/VgatTom mice. Sampled regions are indicated by white boxes in A and B.
Galanin-expressing neurons are shown in green (middle) and Vgat-expressing neurons are shown in red (right). The merged image
(left) shows colocalization of galanin-expressing and Vgat-expressing neurons (yellow, open arrow), even though several non-
Vgat-expressing galanin neurons (green, striped arrow) and non-galanin-expressing Vgat neurons (red, filled arrow) were also
present. E, F, Estimates of cell counts for total galanin GFP neurons and double-labeled galanin GFP/tdTomato neurons in the LHA
and PFA of Gal TgGFP/VgatTom mice expressed as number of cells (E) or as percentage of total galanin neurons (F; n  4). Mean 
SEM. 3V, Third ventricle; DMH, dorsomedial hypothalamus; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; fx, fornix;
PFA, perifornical area; LHA, lateral hypothalamic area; Vgat, vesicular GABA transporter; TdTom, TdTomato reporter gene; Gal,
galanin; tgGFP, transgenic green fluorescence protein.
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ber of sucrose rewards earned (Fig. 2E; paired t test, n  8, t(7) 
2.78, p  0.05) and the total number of correct nose pokes was
likewise increased following CNO injections (Fig. 2F; paired t
test, n  8, t(7)  2.58, p  0.05). However incorrect nose pokes
(no sucrose reward; Fig. 2G) were not changed, indicating a true
increase of motivated behavior (sucrose seeking), rather than
increased impulsive responding.
The operant driven PR task focuses on active food seeking and
less on food consumption. To contrast food seeking with food
consumption, we exposed animals to liquid Ensure (a palatable
complete nutrition beverage) for 1 h over 5 d. CNO or PBS injec-
tions were administered during the last 2 d in DREADD-Gq-
expressing mice and mice that received a control virus injection.
However, palatable food consumption remained unchanged
by activation of LHAGal neurons (Fig. 2H ). This suggests that
activation of LHAGal neurons specifically enhances the moti-
vational aspect of food seeking rather than consumption of
palatable food.
We further wanted to distinguish feeding of palatable food,
which is mainly driven by a hedonic mechanism, from feeding of
Figure 2. Activation of LHAGal neurons increases motivated feeding behavior. A, Illustration of viral injection sites to the LHA in Galanin Cre mice with AAV5-hSyn-DIO-hM3Dq-mCherry
(DREADD-Gq) or AAV5-hSyn-DIO-mCherry (control). B, Representative overview of hM3Dq-mCherry expression in the LHA of Galanin Cre mice. C, Representative images of cFos (green) induction in
mCherry (red) neurons following CNO (1 mg/kg) in LHAGal DREADD-Gq (left) and LHAGal Control (right) mice. D, Experimental procedure scheme for operant conditioning using fixed ratio (FR) and
PR training. E–G, In the operant conditioning PR test, LHAGal DREADD-Gq mice injected with CNO (1 mg/kg, i.p.) significantly increases the total number of sucrose pellet rewards earned (E) and total
number of correct nose pokes (F ), while the total number of incorrect nose pokes was unchanged (G) compared with PBS-injected LHAGal DREADD-Gq mice. H, Total 1 h intake of palatable fat solution
(Ensure) was unchanged in CNO (1 mg/kg)-injected LHAGal DREADD-Gq or LHAGal Control mice. I, Acute (3 h) chow intake was unchanged in CNO (0.3–1 mg/kg, i.p.)-injected LHAGal DREADD-Gq or
LHAGal Control mice. Also 24 h chow intake (inset; 1 mg/kg CNO) was unchanged. J, K, In the food zone experiment (J ), we confirmed that CNO (1 mg/kg) had no effect on the time spent in the food
zone during 3 h after injections (K ). E–G, *p  0.05, n  8, mean  SEM, paired t test. H–K, n  4 control, n  9 DREADD-Gq, two-way ANOVA or two-way repeated-measures ANOVA for
dose–response experiments. 3V, Third ventricle; ME, median eminence; DMH, dorsomedial hypothalamus; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; fx, fornix; LHA, lateral
hypothalamic area; FR, fixed ratio; PR, progressive ratio; DREADD, Designer Receptors Exclusively Activated by Designer Drugs; W, water; F, food; Gal, galanin; PBS, phosphate-buffered saline; CNO,
clozapine-N-oxide.
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regular chow, which is mainly driven by homeostatic mecha-
nisms. This was done in metabolic chambers to allow continuous
(24 h) recording of food intake following CNO (0.3–1 mg/kg)
and PBS injections in control and LHAGal DREADD-Gq mice.
CNO-induced activation of LHAGal neurons did not change 3 or
24 h chow intake (Fig. 2I). We also measured the amount of time
that the mice spent in proximity to the feeding container (Fig. 2J,
Food Zone) over the 3 h following CNO or PBS injections, but the
CNO did not affect the time spent in the food zone of the cage
(Fig. 2K).
Chemogenetic activation of LHA Gal neurons increases
locomotor activity and energy expenditure
LHAGABA neurons have also been implicated in the regulation of
arousal and wakefulness, and we therefore implanted mice with
telemetric radio transmitters to assess the effect of galanin neuron
stimulation on locomotor activity. Animals were implanted with
telemetric radio transmitters for minute-by-minute measure-
ment of locomotor activity. LHAGal DREADD-Gq and control
mice were injected with PBS or CNO (1 mg/kg, i.p.). Indeed,
CNO robustly induced locomotor activity that peaked at 1 h
postinjection and returned to the baseline activity levels 	3 h
postinjection (Fig. 3A). Cumulative locomotor activity (over the
first 3 h postinjection) showed a significant 2.5-fold increase in
locomotor activity in CNO-injected LHAGal DREADD-Gq mice,
but not in control mice (Fig. 3B; LHAGal Control, n  4; LHAGal
DREADD-Gq, n  9; ANOVA for the interaction between treat-
ment and group: F(1,22)  5.071, p  0.05).
We also measured locomotor activity by beam breaks in the TSE
System, which measures 3D movements including up-and-down
rearing, in contrast to the telemetric measurements that exclusively
captures 2D movements in the cage. We confirmed an increase in
locomotor activity following CNO injection, which returned to PBS
baseline levels at 3 h postinjection (Fig. 3C; n  4 LHAGal Control;
n  9 LHAGal DREADD-Gq; repeated-measures ANOVA for the
interaction between group and interval, F(7,77)  6.494; p  0.001).
Comparing cumulative locomotor activity we found a dou-
bling of locomotor activity in LHAGal DREADD-Gq mice at all
tested CNO doses compared with control mice (Fig. 3D;
repeated-measures ANOVA for the interaction between group
and level of drug, F(3,33)  4.584; p  0.01).
We further analyzed VO2 consumption in these mice as loco-
motor activity drives VO2 consumption as a measure for energy
expenditure. CNO consistently increased VO2 mildly compared
with PBS-treated mice (Fig. 3E,F), but only reached significance
at a CNO dose of 1 mg/kg (Fig. 3F; repeated-measures ANOVA
for the interaction between group and level of drug, F(3,33) 
4.413, p  0.01). This further suggests that increased locomotor
activity may also induce locomotion with less effect on oxygen
consumption (e.g., head movements).
Thus, activation of LHAGal neurons showed a clear increase in
locomotor activity that is in line with increased wakefulness dur-
ing the light cycle, where nocturnal mice are typically asleep.
Indeed, while CNO-injected LHAGal DREADD-Gq animals were
awake and engaged in various behaviors, control or PBS-injected
animals were often asleep. Notably, activation of LHAGal neurons
did not induce compulsive-like behavior, in contrast to the com-
pulsive eating or foraging locomotor behavior induced by activa-
tion of LHAGABA neurons as reported by others (Jennings et al.,
2015; Venner et al., 2016).
Chemogenetic activation of LHA GABA neurons increases
food-seeking and food-consumption behavior
To allow a more precise comparison of LHAGABA neurons to
LHAGal neurons, we performed chemogenetic activation of
LHAGABA neurons using the exact experimental setup as used for
chemogenetic activation of LHAGal neurons.
LHAGABA neurons were targeted by viral injections into VgatCre
mice (Vong et al., 2011) using the same stereotaxic coordinates as
described for GalCre mice, with correct viral targeting to the LHA
validated histochemically (Fig. 4A–C). Functional validation was
confirmed by comparing CNO-induced cFos in mCherry
neurons
in LHAVgat DREADD-Gq mice with LHAVgat Control animals. Only
LHAVgat DREADD-Gq mice showed robust CNO-induced cFos in
mCherry
 neurons, while CNO-injected control mice showed only
few cFos
 neurons (Fig. 4B,C).
Food-seeking behavior in LHAVgat DREADD-Gq mice was
examined using the same operant conditioning schedule as for
GalCre mice (Fig. 2D). Initially, when testing operant responding
with a CNO dose of 1 mg/kg, all mice exhibited an erratic,
compulsive-like locomotor behavior (see below) and failed to
perform any significant number of nose pokes (data not shown).
In an effort to moderate this compulsive-like locomotor behav-
ior, we tested all animals with decreasing CNO doses and mea-
sured PR responding for all animals. In seven of eight mice, we
found a CNO dose that increased operant responding. However,
the CNO dose sufficient to enhance operant responding and
low enough to moderate compulsive locomotor activity was
highly variable, possibly due to minute differences in viral
expression levels and anatomical locations. To visualize CNO-
induced operant behavior, we plotted the maximal CNO-
induced operant response for each animal in Figure 4 D, E.
Note that the individual data in Figure 4 D, E were induced by
varying CNO doses. For clarity, we have color-coded the indi-
vidual response data for the used CNO dose in the figure
legend. With this analysis we confirm earlier reports (Jennings
et al., 2015) and show that activation of LHAGABA neurons
increased total number of sucrose rewards earned (Fig. 4E;
paired t test, n  8, t(7)  2.73, p  0.05) and correct nose
pokes (Fig. 4E; paired t test, n  8, t(7)  2.75, p  0.05), but
did not alter the number of incorrect nose pokes (not leading
to sucrose pellet; Fig. 4F ). Neither CNO dose induced incor-
rect nose pokes, indicating that the erratic behavior did not
induce impulsive responding but rather prevented the animals
from engaging in the learned task at all.
Activation of LHAGABA neurons did not change hedonic food
consumption in a paradigm with 1 h access to liquid Ensure (Fig.
4G), but chow consumption over 3 h but not 24 h was increased
by CNO (Fig. 4H; n  4 LHAVgat Control; n  8 LHAVgat
DREADD-Gq, for 0.1 mg/kg CNO: U(3,7)  3.0, T  13.0, p 
0.05; for 0.3 mg/kg CNO: U(3,7)  4.0, T  14.0, p  0.05; 3 h
chow intake at 1 mg failed to reach significance: U(3,7)  6.0, T 
16.0, p  0.10). Note, that these data were generated using de-
creasing doses of CNO (0.1–1 mg/kg, i.p.) as used for LHAGal
neuronal activation, again to moderate compulsive locomotor
behavior. There was high variability among individual mice in
this experiment, with several of the mice demonstrating more
robust increases in food intake during the 3 h period following
CNO injection. Despite the increase in food intake, there was no
increase in time spent in the food zone during the 3 h following
CNO injection for the LHAVgat DREADD-Gq mice (Fig. 4I).
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Chemogenetic activation of LHAGABA neurons increases locomotor
activity more robustly than activation of LHAGal neurons
We further measured locomotor activity following CNO injec-
tion in LHAVgat DREADD-Gq and LHAVgat Control mice using
telemetry in their home cages and beam breaks in metabolic
chambers. We found both measures showed a strong increase in
locomotor activity, which continued to be elevated for 	6 h fol-
lowing injection. Using telemetric monitoring of locomotor ac-
tivity, LHAVgat DREADD-Gq and LHAVgat Control mice were
injected with PBS or CNO (0.1 mg/kg, i.p.). We observed a CNO-
induced increase in locomotor activity that peaked at 1 h postin-
jection and this increase continued until 5 h postinjection before
Figure 3. Activation of LHAGal neurons increases locomotor activity. A, Locomotor activity before and after injection of PBS or CNO (1 mg/kg) in LHAGal DREADD-Gq mice (n  9) as measured by
telemetry in 1 min increments. B, Cumulative locomotor activity (3 h postinjection, measured by telemetry) was significantly increased following CNO (1 mg/kg) injection in LHAGal DREADD-Gq mice
(n 9), but not in LHAGal Control mice (n 4; 2-way ANOVA, pairwise comparisons by Holm–Sidak method). C, Locomotor activity as measured by beam breaks was increased in LHAGal DREADD-Gq
mice following CNO (1 mg/kg) injection compared with LHAGal Controls. D, Different CNO doses (0.3–1 mg/kg, i.p.) were tested for CNO-induced locomotor activity measured by beam breaks and
no reduction in behavioral effects was observed with the tested doses. E, F, Oxygen consumption measurement in metabolic chambers showed only mild effects of CNO (1 mg/kg)-induced locomotor
activity on energy expenditure (E), which was significant only at the highest CNO dose tested (1 mg/kg; F ). C–F, n  4 LHAGal Control; n  9 LHAGal DREADD-Gq, two-way repeated-measures
ANOVA, pairwise comparisons by Holm–Sidak method. All data are represented as mean  SEM, *p  0.05, **p  0.01, and ***p  0.001. LHA, lateral hypothalamic area; DREADD, Designer
Receptors Exclusively Activated by Designer Drugs; Gal, galanin; PBS, phosphate-buffered saline; CNO, clozapine-N-oxide.
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returning to the baseline activity levels (Fig. 5A). Cumulative
locomotor activity (over the first 3 h postinjection) was measured
during the 3 h following CNO or PBS injection showing a signif-
icant 2.5-fold increase in locomotor activity in LHAVgat
DREADD-Gq mice, but not in LHAVgat Control mice (Fig. 5B;
LHAVgat Control, n  4; LHAVgat DREADD-Gq, n  8; ANOVA
for the interaction between treatment and group: F(1,20) 
18.663, p  0.001). These data were similar to data for locomotor
activation of LHAGal neurons. In contrast, locomotor activity mea-
sured by beam breaks (adding up-and-down movements like rear-
ing) in the TSE System reflected a stronger locomotor behavior after
LHAGABA neuron activation compared with activation of LHAGal
neurons. Locomotor activity increased quickly following CNO in-
jection and returned to PBS baseline levels at 6 h postinjection (Fig.
5C; LHAVgat Control, n  4; LHAVgat DREADD-Gq, n  8;
repeated-measures ANOVA for the interaction between group and
interval, F(8,80)  2.771; p  0.01). Comparing cumulative increases
(sum of beam breaks during 3 h following injection) in locomotor
activity, LHAGABA neuronal activation caused a fourfold increase in
locomotor activity at multiple CNO dosages (Fig. 5D; LHAVgat Con-
trol, n  4; LHAVgat DREADD-Gq, n  8; repeated-measures
ANOVA for the interaction between group and level of drug,
F(3,47)  8.389; p  0.001), in contrast to the twofold induc-
tion after LHAGal neuron activation (Fig. 3D).
Energy expenditure (VO2) also increased with activation of
LHAGABA neurons, which extended 	4 h following CNO injection
Figure 4. Activation of LHAGABA neurons increases motivated feeding and chow intake. A, Illustration of viral injection sites to the LHA in VgatCre mice with AAV5-hSyn-DIO-hM3Dq-mCherry
(DREADD-Gq) or AAV5-hSyn-DIO-mCherry (control). B, Representative overview of hM3Dq-mCherry expression in the LHA of VgatCre mice. C, Representative images of cFos (green) induction in
mCherry (red) neurons following CNO (1 mg/kg) in DREADD-Gq (left) and control (right) injected VgatCre mice. D–F, In the operant conditioning PR test, LHAVgat DREADD-Gq mice injected with CNO
(0.05– 0.2 mg/kg, i.p.) significantly increases the total number of sucrose pellet rewards earned (D) and total number of correct nose pokes (E; CNO dose–response experiment was performed and
data are presented as maximal effective CNO dose per individual; green line, 0.05 mg/kg; blue, 0.1 mg/kg; red, 0.2 mg/kg), while the total number of incorrect nose pokes was unchanged
(F ) compared with PBS-injected LHAVgat DREADD-Gq mice. G, Total 1 h intake of palatable fat solution (Ensure) was unchanged in CNO (0.1 mg/kg)-injected LHAVgat DREADD-Gq or LHAVgat Control
mice. H, Acute (3 h) chow intake was increased in CNO (0.1 and 0.3 mg/kg, i.p.)-injected LHAVgat DREADD-Gq compared with LHAVgat Control mice and PBS-injected LHAVgat DREADD-Gq mice.
However, 24 h chow intake (inset; 0.1 mg/kg CNO) was unchanged. I, In the food zone experiment, we confirmed that CNO (0.1 mg/kg) had no effect on the time spent in the food zone during 3 h
postinjection (K ). D–F, *p  0.05, n  8, mean  SEM, paired t test. G–I, n  4 LHAVgat Control; n  8 LHAVgat DREADD-Gq; two-way ANOVA or Mann–Whitney rank sum test for dose–response
experiments. 3V, Third ventricle; ME, median eminence; DMH, dorsomedial hypothalamus; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; fx, fornix; LHA, lateral hypothalamic area;
DREADD, Designer Receptors Exclusively Activated by Designer Drugs; Gal, galanin; PBS, phosphate-buffered saline; CNO, clozapine-N-oxide.
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(Fig. 5E; LHAVgat Control, n  4; LHAVgat DREADD-Gq, n  8;
repeated-measures ANOVA for the interaction between group and
interval, F(8,80)  4.428; p  0.001). Mean VO2 was likewise in-
creased following CNO injection at each dosage of drug tested (0.1–1
mg/kg; Fig. 5F; LHAVgat Control, n  4; LHAVgat DREADD-Gq, n 
8; repeated-measures ANOVA for the interaction between group
and level of drug, F(3,30)  12.026, p  0.001). LHA
GABA neuronal
activation induced a stronger and more prolonged effect on locomo-
tor activity and VO2 than did activation of LHA
Gal neurons, suggest-
ing that galanin neurons in the LHA represent a molecularly distinct
Figure 5. Activation of LHAGABA neurons robustly increases locomotor activity. A, Locomotor activity before and after injection of PBS or CNO (1 mg/kg) in LHAVgat DREADD-Gq mice (n  8) as
measured by telemetry in 1 min increments. B, Cumulative locomotor activity (3 h postinjection, measured by telemetry) was significantly increased following CNO (0.1 mg/kg) injection in LHAVgat
DREADD-Gq mice (n  8), but not in LHAVgat Control mice (n  4; 2-way ANOVA, pairwise comparisons by Holm–Sidak method). C, Locomotor activity as measured by beam breaks was increased
in LHAVgat DREADD-Gq mice following CNO (1 mg/kg) injection compared with LHAVgat Controls. D, Different CNO doses (0.1–1 mg/kg, i.p.) were tested for CNO-induced locomotor activity measured
by beam breaks and no reduction in behavioral effects was observed with the tested doses. E, F, Oxygen consumption measurement in metabolic chambers showed significant effects of CNO (0.1
mg/kg)-induced locomotor activity on energy expenditure (E), which was significant at all CNO doses tested (0.1–1 mg/kg; F ). C–F, n  4 LHAVgat Control; n  8 LHAVgat DREADD-Gq; two-way
repeated-measures ANOVA, pairwise comparisons by Holm–Sidak method. All data are represented as mean  SEM, *p  0.05, **p  0.01, and ***p  0.001. LHA, lateral hypothalamic area;
DREADD, Designer Receptors Exclusively Activated by Designer Drugs; Gal, galanin; PBS, phosphate-buffered saline; CNO, clozapine-N-oxide.
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subset of the overall GABA population in the LHA. It may also sug-
gest a role for a different transmitter system that coexpresses with
GABA, but is distinct from galanin neurons.
LHA GABA neurons, but not LHA Gal neurons, induce
compulsive-like behavior
LHAVgat DREADD-Gq mice showed CNO-induced hyperactive
compulsive-like behavior (i.e., digging in bedding, gnawing on
inedible objects in the cage), and was clearly distinct from CNO-
induced locomotor activity in LHAGal DREADD-Gq mice. To
further examine the nature of the hyperactive behavior following
LHAGABA neuronal activation, we used the marble-burying test.
The marble-burying test is a measure of stereotypical behavior
and is accepted as an indicator of psychiatric conditions, such as
anxiety and obsessive– compulsive disorder. Rodent behavior in
the marble-burying test can be manipulated with common phar-
macological modulators of these conditions, such as anxiolytics
and 5-HT compounds (Deacon, 2006; Angoa-Perez et al., 2013).
LHAGal DREADD-Gq and LHAVgat DREADD-Gq mice demon-
strated a striking difference in CNO-induced marble-burying be-
havior. Compared with control mice, activation of LHAGal
neurons (CNO dose: 1 mg/kg) resulted in significantly fewer bur-
ied marbles (Fig. 6A,C; n  6 LHAGal Control; n  9 LHAGal
DREADD-Gq; T(13)  4.126, p  0.001), while activation of
LHAGABA neurons (CNO dose 0.1 mg/kg) resulted in signifi-
cantly more buried marbles (Fig. 6B,C; n  4 LHAVgat Control;
n  8 LHAVgat DREADD-Gq; T(10)  2.273, p  0.05). These
results provide strong support for a physiological distinction be-
tween LHAGal and the larger LHAGABA neuron population.
Discussion
The LHA modulates food reward and consumption behaviors; how-
ever, the exact role of anatomically and molecularly distinct regions
of LHA neurons and their contribution to these behaviors still re-
main unclear. Our data confirm that LHA neurons and specifically
LHAGABA neurons modulate food reward and consumption behav-
iors. In addition, we distinguish the larger population of LHAGABA
neurons from LHAGal neurons, which represents a subpopulation of
LHAGABA neurons that does not innervate the VTA directly. Overall
our data demonstrate that activation of LHAGal neurons is sufficient
to enhance the motivation to work for food and thus does not re-
quire direct VTA innervation. In contrast, activation of LHAGal neu-
rons did not modulate overall food consumption and thus may
require direct VTA interaction. This further suggests that VTA-
Figure 6. Activation of LHAGal neurons reduces compulsive burying. In contrast, LHAGABA activation increases burying. A, Marble-burying behavior following CNO injection (1 mg/kg) in LHAGal
DREADD-Gq mice (n  9) is decreased compared with LHAGal Control mice (n  6). B, Marble-burying behavior following CNO injection (0.1 mg/kg) LHAVgat DREADD-Gq mice (n  8) is increased
compared with LHAVgat Control mice (n  4). All data are represented as mean  SEM, paired t test, *p  0.05, ***p  0.001. C, Representative images of marble placement at test start (far left),
and at the end of 30 min testing period for LHAGal control (left), LHAGal DREADD-Gq (middle), LHAVgat control (right), and LHAVgat DREADD-Gq (far right). LHA, lateral hypothalamic area; DREADD,
Designer Receptors Exclusively Activated by Designer Drugs; Gal, galanin.
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projecting LHAGABA neurons may mediate the homeostatic food
consumption independently of motivational food seeking. While
our study did not directly address the possible role of the neuropep-
tide galanin per se, our study is the first to use genetically targeted
approaches to investigate the contribution of LHAGal circuitry to
modulate behavioral output.
Modulation of food seeking versus food consumption
Recent studies demonstrated that LHAGABA neurons are potent
modulators of feeding (Jennings et al., 2015; Nieh et al., 2015; Bar-
bano et al., 2016) where activation of overall LHAGABA neurons in-
duced food reward and consumption (Jennings et al., 2015), while
select activation of LHAGABA  VTA circuits exclusively induced
food consumption, but not food reward (Nieh et al., 2015). These
data suggested that non-VTA-projecting LHAGABA neurons are re-
sponsible for mediating food reward. We show that activation of
LHAGal neurons is sufficient to selectively enhance food reward, but
not food consumption. Collectively our data provide evidence that
non-VTA-projecting LHAGal neurons represent LHAGABA neurons
that mediate food-reward behavior and can be contrasted to VTA-
projecting LHAGABA neurons that promote food consumption.
It should be noted that LHAGal neurons strongly innervate
LHA orexin neurons as well as noradrenergic LC neurons (Laque
et al., 2015), which modulate both goal-directed and motivated
behavior (Harris et al., 2005; Hofmeister and Sterpenich, 2015).
Orexin-mediated food reward involves at least in part projections
to the VTA (Peyron et al., 1998; Korotkova et al., 2003; Zheng et
al., 2007; Kempadoo et al., 2013). Nevertheless, the dense orexin
input to the LC that regulates arousal (Bourgin et al., 2000) could
certainly contribute to the overall effect on motivated behavior
and food reward and this possibility will need to be addressed in
future studies.
We also tested palatable food intake after stimulation of either
LHAGal or LHAGABA neurons, but we were unable to confirm
increased consumption of palatable, fat-rich Ensure solution
with LHAGABA neurons (Jennings et al., 2015). However, due to
the large consumption of Ensure (2–3 ml) per test session, we
cannot rule out the possibility that this is due to a ceiling effect
that prevents detection of increased consumption. Together our
data suggest that motivated behavior and overall chow intake is
regulated by distinct LHA neuronal pop-
ulations and that motivated feeding does
not require direct interaction with VTA
neurons.
LHA Gal and LHA GABA neuronal
activation both increase locomotor
activity, with differing behavioral
characteristics
Chemogenetic activation of both LHAGal
and LHAGABA neurons robustly increased
locomotor activity, which was most pro-
nounced in the LHAGABA DREADD-Gq
mice. Recent studies using chemogenetic
and optogenetic methods to investigate
LHAGABA neurons did not evaluate loco-
motor behavior (Jennings et al., 2015;
Nieh et al., 2015). Locomotor activity may
depend on a variety of behavioral changes.
While physical activity and exercise is
tightly bound to changes in energy expen-
diture, other locomotor behaviors may
rather indicate arousal, grooming, and
anxiety, as well as compulsive behaviors. Yet, routine locomotor
assessment (beam breaks, telemetry) is not sufficient to under-
stand the cause for changes in locomotor activity.
Indeed, activation of LHAGal or LHAGABA neurons similarly
induced locomotor activity, even though we observed visually
distinct behavior. Activation of LHAGal neurons increased a
range of typical mouse behavior, such as grooming, digging in the
bedding, and walking, with frequent transitions from one behav-
ior to the other. In contrast, activation of GABA neurons resulted
in repetitive behavior dependent on the environment (e.g., avail-
ability of marbles), but was characterized by compulsive mainte-
nance of one behavior over a long time (e.g., digging, gnawing).
We speculate that the difference in locomotor behaviors is
also based on the presence of LHA  VTA projections that seem
to promote compulsive-like locomotor behavior, while the ab-
sence of LHA  VTA projections diminish compulsive locomo-
tor behavior. This hypothesis is further supported by numerous
publications linking increased dopamine release in the nucleus
accumbens to obsessive– compulsive and repetitive behavior as
well as overall locomotor activity (Molloy and Waddington,
1987; White et al., 1988; Colle and Wise, 1991; Berridge et al.,
2005; Aliane et al., 2009; Kim et al., 2015). Indeed, chemogenetic
activation of GABAergic LHA neurotensin neurons that predom-
inantly act via VTA projections induces dopamine-dependent
locomotor activity (Patterson et al., 2015) and also increases
food-reward behavior (Leinninger et al., 2011; Kempadoo et al.,
2013; Opland et al., 2013), even though compulsivity was not
tested in these studies.
Increased locomotor activity may also reflect arousal, as re-
cently suggested by data showing that LHAGABA neurons inner-
vate the ventral medial preoptic area (VLPO; Venner et al., 2016).
Future studies will have to determine whether LHAGal  orexin
versus LHAGABA  VLPO circuits contribute to different aspects
of arousal and locomotor activity and whether this may also dif-
ferentially affect repetitive compulsive behavior. Several studies
mentioned induction of compulsive-like behaviors following
chemogenetic or optogenetic activation of LHAGABA or
LHAGABA  VTA projections (Nieh et al., 2015; Navarro et al.,
2016; Venner et al., 2016), so that an LHA  VTA-mediated
compulsive behavior is strongly suggested.
Figure 7. Proposed circuit for LHAGal and LHAGABA behavioral phenotypes. We propose that LHAGABA/galanin-positive neurons
modulate motivated feeding via non-VTA projections such as the LC or Hcrt/Ox population within the LHA. Nongalaninergic
LHAGABA neurons modulate consummatory behavior along with compulsive behaviors via VTA projections. LHA, lateral hypotha-
lamic area; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; fx, fornix; opt, optic tract; mt, mammillothalamic tract; VTA,
ventral tegmental area; Hcrt/Ox, Hypocretin/orexin; LC, locus coeruleus; Gal, galanin.
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Anatomical considerations and other neurotransmitters
Our data collected from the Gal TgGFP/VgatTom mice show that
only half of LHAGal neurons coexpress GABA, so that other neu-
rotransmitters and/or neuropeptides may contribute to the ob-
served effects. LHAGal and LHAGABA neurons do not express
hypocretin/orexin (Hcrt/Ox) or melanin-concentrating hor-
mone, but do innervate Hcrt/Ox neurons (Jennings et al., 2015;
Laque et al., 2015). A portion of LHAGal neurons coexpress neu-
rotensin and cocaine-and-amphetamine-regulated transcript, as
well as the long-form leptin receptor (LepRb; Laque et al., 2013),
which are all mediators of anorexigenic action.
Our previous work suggested that LepRb-expressing LHAGal
neurons mediate food reward via inhibitory inputs to Hcrt/Ox
(Laque et al., 2015), either via inhibitory GABA or galanin signal-
ing (Goforth et al., 2014). However, activation of LHAGal neurons
induced food reward so that indirect actions of GABAergic
LHAGal neurons are likely. Indeed, activation of LHAGal or
LHAVgat both seemed to induce cFos in Hcrt/Ox neurons (data
not shown), suggesting indirect actions involving disinhibition
via interneurons or feedforward mechanisms via effects on the
first-order projection sites in other brain regions (e.g., LC or
VTA). We further observed strong cFos induction in non-
Hcrt/Ox neurons, with some of these likely reflecting primary
activated LHAGal or LHAVgat neurons. However, given the extent
of cFos-positive non-Hcrt/Ox neurons, we cannot rule out the
possibility that other, unidentified LHA populations are equally
involved in mediating reward behavior.
Thus, the role of Hcrt/Ox neurons to mediate LHAGal signals
requires further investigation. LHAGal neurons, similar to
Hcrt/Ox neurons, strongly innervate the LC (Carter et al., 2012;
Laque et al., 2015). The Hcrt/Ox  LC axis mediates arousal
(Carter et al., 2012) and the LC is generally associated with the
modulation of goal-directed behavior (Usher et al., 1999; Bouret
and Richmond, 2015). Thus, further studies will have to clarify
whether the LC is a relevant mediator of the observed effects in
food-reward and locomotor activity.
Recent studies have shown that within the LHAGABA population,
discrete groups of GABA neurons are differentially activated during
select feeding behaviors (Jennings et al., 2015), suggesting the exis-
tence of functionally distinct neuronal populations. Indeed, discrete
populations of LHAGABA  VTA terminals respond differentially to
varying degrees of optogenetic parameters, such as laser frequency
and duration (Barbano et al., 2016). While LHA  VTA projections
generally enhanced food reward and consumption, LHAGABA 
VTA projection selectively modulated food consumption, indicat-
ing that non-VTA-projecting LHAGABA neurons are required for
LHAGABA-induced food reward.
Our data indicate that LHAGal neurons represent these non-
VTA-projecting LHAGABA neurons that selectively modulate
food reward. Furthermore, activation of LHAGABA neurons, but
not LHAGal neurons, induced compulsive locomotor activity. We
further propose that compulsive locomotor behavior requires
LHAGABA innervation of the VTA, which is supported by Nieh
and colleagues reporting that activation of LHAGABA  VTA ter-
minals increased maladaptive gnawing behavior (Nieh et al.,
2015).
In summary, we show that LHAGal neurons represent a pop-
ulation of LHAGABA neurons that do not directly innervate the
VTA and are sufficient to modulate food reward. We propose
that the effect of LHAGal stimulation on motivated behavior relies
on direct or indirect projections to Hcrt/Ox and/or the LC (Fig.
7). Further, LHAGal neurons induce motivated feeding and locomo-
tor activity without changes in daily caloric intake or compulsive/
repetitive behaviors, which could have important implications for
treatment strategies for feeding disorders and compulsive behaviors.
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